Picture of Newron Pharmaceuticals SpA logo

NWRN — Newron Pharmaceuticals SpA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Europe Research Roundup: Burberry, Rolls Royce, TI Fluid Systems

March 17 (Reuters) - Securities analysts revised their ratings and price targets on several
European companies, including Burberry, Rolls Royce and TI Fluid Systems on Wednesday. 
    
    HIGHLIGHTS
     * Burberry  BRBY.L : Jefferies raises target price to 2050p from 1700p
     * Rolls Royce  RR.L : JP Morgan raises to neutral from underweight
     * TI Fluid Systems  TIFS.L : Deutsche Bank cuts to hold from buy
      
Following is a summary of research actions on European companies reported by Reuters on
Wednesday. Stock entries are in alphabetical order. 
    
     * Alstom  ALSO.PA : JP Morgan cuts target price to EUR 51 from EUR 52
     * Brenntag SE  BNRGn.DE : Citigroup raises price target to EUR 78 from EUR 75
     * Burberry  BRBY.L : Jefferies raises target price to 2050p from 1700p
     * Ferguson  FERG.L : JP Morgan raises price target to 8900p from 8700p
     * Gamesys  GYS.L : Jefferies raises target price to 2150p from 1930p
     * Morphosys AG  MORG.DE : SVB Leerink cuts price target to EUR 88 from EUR 119
     * Newron Pharmaceuticals SpA  NWRN.S : Jefferies cuts target price to CHF 5 from CHF 6.5
     * Petrofac  PFC.L : RBC cuts price target to 108p from 170p
     * Poste Italiane  PST.MI : Citigroup raises price target to EUR 11.8 from EUR 11
     * Rolls Royce  RR.L : JP Morgan raises price target to 105p from 45p
     * Rolls Royce  RR.L : JP Morgan raises to neutral from underweight
     * St. James's Place  SJP.L : RBC raises target price to 1,150p from 975p
     * TI Fluid Systems  TIFS.L : Deutsche Bank cuts to hold from buy
     * Volkswagen AG  VOWG_p.DE : CFRA raises target price to EUR 194 from EUR 159
     * Wienerberger AG  WBSV.VI : Citigroup raises price target to EUR 31 from EUR 28.1
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Newron Pharmaceuticals SpA

See all news